Search results
Results From The WOW.Com Content Network
Cassava (Manihot esculenta) production is important to the economy of Democratic Republic of the Congo (DRC). It is one of the country's principal crops, with per capita consumption of 353 kg per year, which is the highest in the world. [1] Zaire, now the DRC, was the world's largest consumer of cassava with Republic of the Congo ranked second ...
Cassava is the country's main food. [6] Cassava production and consumption have generally matched since the early 1990s. In 1999, cassava accounted for 90% of the country's food output. [7] In 2008, the production reported was 1.09 million tons. However, in recent years production is said to have exceeded consumption.
The Food and Agriculture Organization (FAO) Food Price Index 1961–2021 in nominal and real terms. The Real Price Index is the Nominal Price Index deflated by the World Bank Manufactures Unit Value Index (MUV). Years 2014–2016 is 100. Food prices refer to the average price level for food across countries, regions and on a global scale. [1]
Its cultivation increased rapidly in the early 1980s. In 1985 283,000 tonnes of cassava was made, 23% larger than the previous year. The same increase happened with the area harvested (113 100 ha) and yield per ha (2500 kg). Most Liberian cassava is processed into various forms for human consumption.
Cassava starch: Cassava starch is a fine powder derived from cassava roots through a process of extraction, dewatering, and drying. It has a broad range of applications in both food and non-food industries, including paper manufacturing, printing, textiles, cosmetics, and ethanol production.
Will be right back... Thank you for your patience. Our engineers are working quickly to resolve the issue.
Cassava grows well within 30° of the equator, where it can be produced at up to 2,000 m (7,000 ft) above sea level, and with 50 to 5,000 mm (2 to 200 in) of rain per year. These environmental tolerances suit it to conditions across much of South America and Africa.
The development of Cassava Sciences’ (SAVA) Alzheimer treatment appears to be rolling along smoothly. On Monday, the biotech said its End-of Phase 2 (EOP2) mid-January meeting with the FDA had ...